...
首页> 外文期刊>Circulation. Cardiovascular interventions >Timing of mortality after severe bleeding and recurrent myocardial infarction in patients with ST-segment-elevation myocardial infarction
【24h】

Timing of mortality after severe bleeding and recurrent myocardial infarction in patients with ST-segment-elevation myocardial infarction

机译:ST段抬高型心肌梗死患者严重出血和复发性心肌梗死后的死亡时间

获取原文
获取原文并翻译 | 示例

摘要

Background-The prognosis of initial survivors of ST-segment-elevation myocardial infarction (STEMI) is affected by both recurrent myocardial infarction (MI) and severe bleeding. The aim of the current study was to investigate how mortality is affected in time after bleeding and recurrent MI. Methods and Results-From January 1, 2003, to July 31, 2008, a total of 2002 patients were treated with primary percutaneous coronary intervention for ST-segment-elevation MI and followed up for the occurrence of recurrent MI and Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) severe bleeding. Primary outcome was all-cause mortality within 4 years of follow-up. In a time-dependent, covariate-adjusted Cox regression model, both bleeding and recurrent MI were associated with an increase in mortality shortly after the adverse event: hazard ratio, 14.37 (95% confidence interval [CI], 7.69-26.84) for the first day after recurrent MI and 5.42 (95% CI, 2.88-10.22) for the first day after bleeding. Thereafter the risk of subsequent mortality gradually decreased but remained elevated long after a recurrent MI (hazard ratio, 4.95 [95% CI, 3.27-7.48] between 1 day and 1 year after recurrent MI and hazard ratio, 2.56 [95% CI, 1.56-4.21] beyond 1 year after recurrent MI), but decreased to nonsignificant level beyond 1 month after the bleeding (hazard ratio, 0.56 [95% CI, 0.27-1.14]). Conclusions-The occurrence of both recurrent MI and bleeding in the first year after ST-segment-elevation MI is associated with subsequent mortality. The risk implication of recurrent MI, however, was greater and more sustained over time than that of severe bleeding.
机译:背景-ST段抬高型心肌梗死(STEMI)的最初存活者的预后受复发性心肌梗塞(MI)和严重出血的影响。本研究的目的是调查出血和复发性MI后如何及时影响死亡率。方法和结果-从2003年1月1日至2008年7月31日,总共2002例患者接受了原发性经皮冠状动脉介入治疗以治疗ST段抬高型心肌梗塞,并随访了复发性MI的发生以及链球菌激酶和闭塞性动脉组织纤溶酶原激活剂(GUSTO)严重出血。主要结局是随访4年内的全因死亡率。在时间依赖性,协变量调整的Cox回归模型中,出血和复发性MI均与不良事件发生后不久死亡率增加有关:危险比为14.37(95%置信区间[CI],7.69-26.84)。复发性心肌梗死后第一天,出血后第一天为5.42(95%CI,2.88-10.22)。此后,随后发生死亡的风险逐渐降低,但在复发性心肌梗死后很长一段时间内仍保持升高(风险比,复发性心肌梗死后1天至1年之间为4.95 [95%CI,3.27-7.48],风险比为2.56 [95%CI,1.56] -4.21]在MI复发后1年以上),但在出血后1个月后降至无显着水平(危险比,0.56 [95%CI,0.27-1.14])。结论:ST段抬高型心梗发生后的第一年,复发性心梗和出血的发生与随后的死亡率有关。但是,随着时间的流逝,MI复发的风险比严重出血的风险更大并且更持久。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号